Details

Autor(en) / Beteiligte

• Grosse, Gerrit M
• Biber, Saskia
• Sieweke, Jan-Thorben
• Martens-Lobenhoffer, Jens
• Gabriel, Maria M
• Putzer, Anne-Sophie
• Hasse, Isabel
• van Gemmeren, Till
• Schuppner, Ramona
• Worthmann, Hans
• Lichtinghagen, Ralf
• Bode-Böger, Stefanie M
• Bavendiek, Udo
• Weissenborn, Karin

Titel

Plasma Dimethylarginine Levels and Carotid Intima⁻Media Thickness are related to Atrial Fibrillation in Patients with Embolic Stroke

Ist Teil von

• International journal of molecular sciences, 2019-02, Vol.20 (3), p.730

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2019

Quelle

Elektronische Zeitschriftenbibliothek (Open access)

Beschreibungen/Notizen

• A relevant part of embolic strokes of undetermined source (ESUS) is assumed to be due to non-detected atrial fibrillation (AF). In this study, we aimed to investigate if markers of endothelial dysfunction and damage may indicate AF risk in embolic stroke. Eighty-eight patients with ischemic stroke confirmed by imaging were assigned to one of three groups: ESUS, AF, or micro-/macroangiopathy. ESUS patients underwent prolonged Holter electrocardiography scheduled for three days. The National Institutes of Health Stroke Scale (NIHSS), the CHA₂DS₂VASC score, and the carotid intima⁻media thickness (CIMT) were obtained. Markers of endothelial (dys)function (L-arginine, asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA)) were measured at day seven after stroke. ESUS patients were younger and had fewer cardiovascular risk factors than patients with determined stroke etiology. Compared with AF patients, ESUS patients showed significantly lower values of SDMA ( = 0.004) and higher values of L-arginine ( = 0.031), L-arginine/ADMA ratio ( = 0.006), L-arginine/SDMA ratio ( = 0.002), and ADMA/SDMA ratio ( = 0.013). Concordant differences could be observed comparing ESUS patients with those with newly diagnosed AF ( = 0.026; = 0.03; = 0.009; = 0.004; and = 0.046, respectively). CIMT was significantly larger in AF than in ESUS patients ( < 0.001), and was identified as an AF risk factor independent from CHA₂DS₂VASC in the regression analysis ( = 0.014). These findings may support future stratification for AF risk in patients who have suffered embolic stroke.